Reports for RISPERIDONE

Ingredient

RISPERIDONE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-RISPERIDONE 2.0MG TABLET Resolved 2023-05-19 2023-08-04 192803
APO-RISPERIDONE 2.0MG TABLET Resolved 2023-05-19 2023-08-04 192821
APO-RISPERIDONE 2.0MG TABLET Resolved 2023-09-22 2023-12-01 205002
APO-RISPERIDONE 2.0MG TABLET Resolved 2023-12-22 2024-05-03 214247
APO-RISPERIDONE 2.0MG TABLET Resolved 2024-03-01 2024-04-26 221090
SANDOZ RISPERIDONE 2.0MG TABLET Resolved 2020-05-11 2020-05-25 114663
JAMP-RISPERIDONE 2.0MG TABLET Resolved 2017-03-30 2017-09-27 4786
JAMP-RISPERIDONE 2.0MG TABLET Resolved 2017-03-30 2017-09-27 4789
JAMP-RISPERIDONE 2.0MG TABLET Resolved 2022-04-06 2022-05-17 158094
JAMP-RISPERIDONE 2.0MG TABLET Resolved 2022-04-06 2022-05-17 158097

Showing 81 to 90 of 138

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
RISPERDAL 0.25MG TABLET Discontinued 2018-11-29 2019-04-02 68095
MYLAN-RISPERIDONE 0.25MG TABLET Discontinued 2017-07-18 2018-02-15 16154
MYLAN-RISPERIDONE 0.50MG TABLET Discontinued 2017-07-18 2018-02-15 16157
RISPERDAL 0.5MG TABLET Discontinued 2018-11-29 2019-04-02 68098
MYLAN-RISPERIDONE ODT 0.5MG TABLET (ORALLY DISINTEGRATING) Discontinued 2021-11-23 2021-11-23 149759
SANDOZ RISPERIDONE 1.0MG TABLET Discontinued 2021-08-19 2021-08-19 144338
MYLAN-RISPERIDONE 1.0MG TABLET Discontinued 2017-07-18 2017-09-08 16160
RISPERDAL 1MG TABLET Discontinued 2018-11-29 2019-04-02 68085
RISPERDAL ORAL SOLUTION 1MG SOLUTION To be discontinued 2023-04-27 2023-04-27 190894
MYLAN-RISPERIDONE ODT 1MG TABLET (ORALLY DISINTEGRATING) Discontinued 2021-11-23 2021-11-23 149762

Showing 1 to 10 of 29